Summary
Cardinal Health Inc. (CAH) announced a significant restructuring initiative impacting its Medical segment. The company expects to incur pre-tax costs of $130 million related to the transition of its surgeon glove distribution in certain international markets from a third-party model to a direct distribution model. This strategic shift is designed to enhance control and potentially efficiency in its global operations. This restructuring involves the termination of an agreement with a third-party distributor and is anticipated to be completed in 2018. The majority of the costs, $125 million, are attributed to contract termination fees, with the remaining $5 million covering other associated expenses. Investors should note that $125 million of these costs were recognized in the quarter ending September 30, 2017, with the remainder expected in fiscal year 2018. While the company anticipates benefits from this transition, it also cautions that actual costs and outcomes may differ from current estimates, highlighting typical business risks associated with such strategic changes.
Key Highlights
- 1Cardinal Health is undertaking a restructuring in its Medical segment to transition international surgeon glove distribution from third-party to direct. This is expected to incur $130 million in pre-tax costs.
- 2The majority of the restructuring costs ($125 million) are due to contract termination fees with a third-party distributor.
- 3The transition is expected to be completed in 2018.
- 4A significant portion of the costs ($125 million) were already incurred in the quarter ending September 30, 2017.
- 5The remaining costs are expected to be recognized in the fiscal year ending June 30, 2018.
- 6All restructuring costs are expected to result in cash expenditures and will be recorded in the restructuring and employee severance line item.
- 7The company acknowledges that estimates may change and includes cautionary statements regarding forward-looking risks and uncertainties.